Company intelligence / Profile preview

AngioAdvancements

Fort Myers, Florida, United Statesangioadvancements.com ↗

Ownership: Private
Employees: ~8
Development stage: Other

Overview

AngioAdvancements markets proprietary disposable medical devices—primarily the CO2mmander® ELITE Portable Medical CO2 Delivery System and the AngiAssist® Medical Gas Management System—for use in interventional and diagnostic procedures. These FDA-exempt Class I devices are widely accepted by physicians for safe delivery of medical gases, especially carbon dioxide, in vascular and endoscopic interventions. The company emphasizes cost reduction per episode of care and broad clinical utility.

Therapeutic areas: GastroenterologyOncologyCardiovascularOther
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Robling Medical (manufacturing partner for AngiAssist)Portable Medical Devices (manufacturing partner for CO₂mmander ELITE)

Beyond the preview

Go deeper on AngioAdvancements.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AngioAdvancements.

Explore the full profile